ONCOLOGY

Results of a 49-study meta-analysis.

Risks change over time, and conditional RFS could provide a more accurate prognosis.

Prior data focused on intermediate- to advanced-stage hepatocellular carcinoma.

HCC recurrence risk drops with DAA delay.

Risk is even higher with male sex, high BMI, hypertension, and kidney disease markers.

Combines the effectiveness of open resection and the safety profile of RFA.

The study is the first meta-analysis comparing MIS and RFA in small HCC.

Reducing exposure in select patients could help prevent acute and long-term toxicities.

Real-world data suggest effect driven by preserved hepatic function.

1.7% of US births result from IVF.

RAS status and NACT response should be considered.

Daily low-dose aspirin demonstrates potential preventive effect.

SEER analysis compares HR and RFA by age and tumor size.

Practice update from the American Gastroenterological Association.